All
Aerospace, Defense & Security
Agriculture
Banking, Financial Services & Insurance
Chemicals, Materials & Polymers
Energy & Power
FMCG & Consumer Products
Healthcare & Life Sciences
Heavy Machinery & Equipment
Industrial Automation & Mobility
Information Technology & Electronics
Healthcare-Life-Sciences Market Reports
Comprehensive industry analysis, market size, and forecast for healthcare-life-sciences.
Showing 121 - 130 of 909 reports
Spain Gastritis Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 387.4 million Market Size 2032: USD 621.8 million CAGR: 6.1% Market Definition: The Spain gastritis treatment market encompasses pharmaceutical therapies, diagnostic services, and clinical management protocols for acute and chronic gastritis, including H. pylori eradication regimens, proton pump inhibitors, …
Read More
India Gastritis Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.82 billion Market Size 2032: USD 3.11 billion CAGR: 6.9% Market Definition: The India gastritis treatment market encompasses pharmaceutical therapies, diagnostic services, and clinical interventions used to manage acute and chronic gastric mucosal inflammation, including H. pylori eradication regimens, …
Read More
Italy Gastritis Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Country: Italy Market: Gastritis Treatment Market Market Size 2024: USD 1.04 Billion Market Size 2032: USD 1.61 Billion CAGR: 5.6% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — H. pylori Prevalence Drives Volume: Italy carries one of Western …
Read More
Yellow Fever Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.2 billion Market Size 2034: USD 2.1 billion CAGR: 5.8% Market Definition: The yellow fever treatment market encompasses vaccines, supportive care therapeutics, diagnostics, and hospital management protocols used to prevent and manage yellow fever virus infections globally. It includes …
Read More
Vestibular Neuronitis Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2034: USD 2.61 Billion CAGR: 6.3% Market Definition: The vestibular neuronitis treatment market encompasses pharmaceuticals, vestibular rehabilitation therapies, and diagnostic services used to manage acute vertigo and balance dysfunction caused by vestibular nerve inflammation. It …
Read More
Vasovagal Syncope Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The vasovagal syncope treatment market encompasses pharmacological agents, implantable devices, and non-pharmacological interventions used to prevent and manage reflex-mediated fainting episodes triggered by autonomic nervous system dysfunction. …
Read More
Zollinger Ellison Syndrome Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.84 billion Market Size 2034: USD 3.12 billion CAGR: 5.4% Market Definition: The Zollinger-Ellison Syndrome (ZES) treatment market encompasses pharmaceutical and surgical interventions targeting gastrin-secreting tumors (gastrinomas) and their associated hypersecretory acid conditions. It includes proton pump inhibitors, somatostatin …
Read More
Animal Anti-Rabies Vaccine Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The animal anti-rabies vaccine market encompasses biological products designed to immunise domestic animals, livestock, and wildlife against the rabies virus. It includes inactivated, live-attenuated, and recombinant vaccine …
Read More
X-Linked Hypophosphatemia (XLH) Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $1.84 billion Market Size 2034: $4.12 billion CAGR: 8.4% Market Definition: The XLH treatment market encompasses pharmaceutical therapies, including FGF23-inhibiting biologics and conventional phosphate-vitamin D supplementation regimens, used to manage X-Linked Hypophosphatemia, a rare hereditary phosphate-wasting disorder caused by PHEX …
Read More
Biotechnology Contract Manufacturing Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 22.4 billion Market Size 2034: USD 61.8 billion CAGR: 10.7% Market Definition: The biotechnology contract manufacturing market encompasses third-party organisations that produce biologics, cell and gene therapies, vaccines, and related products on behalf of pharmaceutical and biotech companies. Services …
Read More